Anke Kretz-Rommel

1.9k total citations
31 papers, 1.5k citations indexed

About

Anke Kretz-Rommel is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Pharmacology. According to data from OpenAlex, Anke Kretz-Rommel has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Pharmacology. Recurrent topics in Anke Kretz-Rommel's work include T-cell and B-cell Immunology (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Immune Cell Function and Interaction (10 papers). Anke Kretz-Rommel is often cited by papers focused on T-cell and B-cell Immunology (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Immune Cell Function and Interaction (10 papers). Anke Kretz-Rommel collaborates with scholars based in United States, Switzerland and Netherlands. Anke Kretz-Rommel's co-authors include Urs A. Boelsterli, Katherine S. Bowdish, Robert L. Rubin, Fenghua Qin, Hyman J. Zimmerman, Naveen Dakappagari, Toshiaki Maruyama, Dayang Wu, Daniela I. Oltean and Susan J. Faas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Anke Kretz-Rommel

30 papers receiving 1.4k citations

Peers

Anke Kretz-Rommel
Yuichi Aiba Japan
Mary A. Mulkins United States
Gerald Künstle Germany
Gerald Nabozny United States
Ming‐Chei Maa Taiwan
Anne M. Pilaro United States
Robert W. Marquis United States
Ping He China
Wendy A. Teft Canada
Takumi Shiraishi Japan
Yuichi Aiba Japan
Anke Kretz-Rommel
Citations per year, relative to Anke Kretz-Rommel Anke Kretz-Rommel (= 1×) peers Yuichi Aiba

Countries citing papers authored by Anke Kretz-Rommel

Since Specialization
Citations

This map shows the geographic impact of Anke Kretz-Rommel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Kretz-Rommel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Kretz-Rommel more than expected).

Fields of papers citing papers by Anke Kretz-Rommel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Kretz-Rommel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Kretz-Rommel. The network helps show where Anke Kretz-Rommel may publish in the future.

Co-authorship network of co-authors of Anke Kretz-Rommel

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Kretz-Rommel. A scholar is included among the top collaborators of Anke Kretz-Rommel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Kretz-Rommel. Anke Kretz-Rommel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blanchetot, Christophe, Natalie De Jonge, Aline Desmyter, et al.. (2016). Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies. Journal of Biological Chemistry. 291(26). 13846–13854. 28 indexed citations
2.
Klarenbeek, A., Christophe Blanchetot, Wieger Hemrika, et al.. (2016). Combining somatic mutations present in differentin vivoaffinity-matured antibodies isolated from immunizedLama glamayields ultra-potent antibody therapeutics. Protein Engineering Design and Selection. 29(4). 123–133. 9 indexed citations
3.
Allen, Joshua E., Roger Ferrini, David T. Dicker, et al.. (2012). Targeting TRAIL Death Receptor 4 with Trivalent DR4 Atrimer Complexes. Molecular Cancer Therapeutics. 11(10). 2087–2095. 25 indexed citations
4.
Webb, David R., Tracy M. Handel, Anke Kretz-Rommel, & Raymond C. Stevens. (2012). Opportunities for functional selectivity in GPCR antibodies. Biochemical Pharmacology. 85(2). 147–152. 37 indexed citations
5.
Tacken, Paul J., Ben Joosten, Anita Reddy, et al.. (2008). No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation. The Journal of Immunology. 180(11). 7687–7696. 34 indexed citations
6.
Siva, Amara C., et al.. (2007). Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200. Cancer Immunology Immunotherapy. 57(7). 987–996. 89 indexed citations
7.
Kretz-Rommel, Anke, Fenghua Qin, Naveen Dakappagari, et al.. (2007). In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models. Journal of Immunotherapy. 30(7). 715–726. 71 indexed citations
8.
Pereira, Cândida F., Ruurd Torensma, Konnie M. Hebeda, et al.. (2007). In Vivo Targeting of DC-SIGN-positive Antigen-presenting Cells in a Nonhuman Primate Model. Journal of Immunotherapy. 30(7). 705–714. 29 indexed citations
9.
Kretz-Rommel, Anke & Katherine S. Bowdish. (2007). Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression. Expert Opinion on Biological Therapy. 8(1). 5–15. 36 indexed citations
10.
Dakappagari, Naveen, Toshiaki Maruyama, Mark W. Renshaw, et al.. (2006). Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses. The Journal of Immunology. 176(1). 426–440. 39 indexed citations
11.
McWhirter, John R., Anke Kretz-Rommel, Alan Saven, et al.. (2006). Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proceedings of the National Academy of Sciences. 103(4). 1041–1046. 130 indexed citations
12.
Kretz-Rommel, Anke & Robert L. Rubin. (2001). Early Cellular Events in Systemic Autoimmunity Driven by Chromatin-Reactive T Cells. Cellular Immunology. 208(2). 125–136. 9 indexed citations
13.
Rubin, Robert L. & Anke Kretz-Rommel. (2001). Phagocyte-mediated oxidation in idiosyncratic adverse drug reactions. Current Opinion in Hematology. 8(1). 34–40. 8 indexed citations
14.
Kretz-Rommel, Anke & Robert L. Rubin. (2000). Disruption of positive selection of thymocytes causes autoimmunity. Nature Medicine. 6(3). 298–305. 54 indexed citations
15.
Kretz-Rommel, Anke, et al.. (1999). Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus.. Environmental Health Perspectives. 107(suppl 5). 803–806. 19 indexed citations
16.
Kretz-Rommel, Anke & Robert L. Rubin. (1999). Persistence of Autoreactive T Cell Drive Is Required to Elicit Anti-Chromatin Antibodies in a Murine Model of Drug-Induced Lupus. The Journal of Immunology. 162(2). 813–820. 23 indexed citations
17.
Rubin, Robert L. & Anke Kretz-Rommel. (1999). Linkage of Immune Self-Tolerance with the Positive Selection of T Cells. Critical Reviews in Immunology. 19(3). 20–20. 13 indexed citations
18.
Kretz-Rommel, Anke, Steven R. Duncan, & Robert L. Rubin. (1997). Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.. Journal of Clinical Investigation. 99(8). 1888–1896. 53 indexed citations
19.
Boelsterli, Urs A., Hyman J. Zimmerman, & Anke Kretz-Rommel. (1995). Idiosyncratic Liver Toxicity of Nonsteroidal Antiinflammatory Drugs: Molecular Mechanisms and Pathology. Critical Reviews in Toxicology. 25(3). 207–235. 142 indexed citations
20.
Kretz-Rommel, Anke & Urs A. Boelsterli. (1995). Cytotoxic activity of T cells and non-T cells from diclofenac-immunized mice against cultured syngeneic hepatocytes exposed to diclofenac. Hepatology. 22(1). 213–222. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Aiba Breakdown of academic impact, for papers by Mary A. Mulkins Breakdown of academic impact, for papers by Gerald Künstle Breakdown of academic impact, for papers by Gerald Nabozny Breakdown of academic impact, for papers by Ming‐Chei Maa Breakdown of academic impact, for papers by Anne M. Pilaro Breakdown of academic impact, for papers by Robert W. Marquis Breakdown of academic impact, for papers by Ping He Breakdown of academic impact, for papers by Wendy A. Teft Breakdown of academic impact, for papers by Takumi Shiraishi
Rankless by CCL
2026